The DELIVER EID programme aims to equip 6 industrial PhD graduates with all of the tools required to become creative, entrepreneurial and innovative leaders in the emerging European advanced therapies sector. Advanced therapies are new medicinal products based on genes or cells and tissue engineering products (biomaterials), sometimes used in combination with medical devices. They herald revolutionary treatments for a number of chronic diseases including Alzheimer’s, cancer and the focus of the DELIVER programme, Diabetes Mellitus. We aim to DELIVER the next cohort of translational research scientists in the field of advanced therapies and enabling medical devices for pancreatic islet transplantation, a cell therapy which is poised to become more widespread for the treatment of insulin-dependent diabetes. The DELIVER doctoral training network therefore represents a major interdisciplinary effort between cell biologists, experts in biomaterials, medical devices and advanced drug delivery, clinical experts in islet transplantation and research-active biotech and biomedical companies.
NUI Galway (Coordinator), Eberhard Karls Universitaet Tuebingen, Explora SRL, L'azienda Socio Sanitaria Territoriale (Asst) Grande, Ospedale Metropolitano Niguarda, Boston Scientific LTD.